Literature DB >> 12362105

Prothrombin index is an indirect marker of severe liver fibrosis.

Vincent Croquet1, Eric Vuillemin, Catherine Ternisien, Christophe Pilette, Frédéric Oberti, Yves Gallois, Marc Trossaert, Marie Christine Rousselet, Daniel Chappard, Paul Calès.   

Abstract

OBJECTIVE: The non-invasive diagnosis of liver fibrosis is based mainly on biochemical markers. The main aim was to validate whether the prothrombin index is an indirect marker of the severity of liver fibrosis. PATIENTS AND METHODS: The predictive value of the prothrombin index for liver fibrosis was first assessed in 243 patients with chronic liver disease, then validated in 193 other patients with chronic liver disease. The reproducibility of measurement of the prothrombin index in different laboratories was evaluated in 82 other patients.
RESULTS: In the first group, the prothrombin index was predicted accurately by serum hyaluronate (R(2)= 0.67 at the first step by multiple regression). The relationship between the prothrombin index and the area of fibrosis was not influenced significantly by non-fibrotic pathological lesions. The prothrombin index began to decrease when the Metavir fibrosis score was 2 versus 3 for albumin. In the second group, the prothrombin index and the histological fibrosis score were well correlated (r= -0.70, P< 10(-4)). Prothrombin index < or =80% or < or =70% diagnosed severe fibrosis or cirrhosis, respectively, and prothrombin index > or =105% or > or =100% excluded a diagnosis of severe fibrosis or cirrhosis, respectively, at the 95% probability level. The prothrombin indices measured in different laboratories were similar (78+/-18% v. 78+/-14%) and well correlated (r= 0.91, P< 10(-4)).
CONCLUSIONS: The prothrombin index was well correlated with pathological liver fibrosis score, had a high diagnostic accuracy for severe fibrosis or cirrhosis especially due to alcohol, and was not influenced by other pathological lesions. The prothrombin index was reproducible. Thus, the prothrombin index expressed as a percentage is an accurate, reproducible, inexpensive and easily available marker of severe liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12362105     DOI: 10.1097/00042737-200210000-00015

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  14 in total

1.  Efficacy of telbivudine in the treatment of chronic hepatitis b and liver cirrhosis and its effect on immunological responses.

Authors:  Nan Meng; Xiao Gao; Wei Yan; Mi Wang; Ping Liu; Xiao-Dan Lu; Shu-Juan Zhang; Ya-Qi Lu; Wang-Xian Tang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

2.  Non-invasive diagnosis of liver fibrosis.

Authors:  Hiroyasu Morikawa; Norifumi Kawada
Journal:  Clin J Gastroenterol       Date:  2011-07-31

Review 3.  Alcoholic liver disease.

Authors:  Helmut K Seitz; Ramon Bataller; Helena Cortez-Pinto; Bin Gao; Antoni Gual; Carolin Lackner; Philippe Mathurin; Sebastian Mueller; Gyongyi Szabo; Hidekazu Tsukamoto
Journal:  Nat Rev Dis Primers       Date:  2018-08-16       Impact factor: 52.329

Review 4.  Non-invasive diagnosis of alcoholic liver disease.

Authors:  Sebastian Mueller; Helmut Karl Seitz; Vanessa Rausch
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

5.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.

Authors:  J Foucher; E Chanteloup; J Vergniol; L Castéra; B Le Bail; X Adhoute; J Bertet; P Couzigou; V de Lédinghen
Journal:  Gut       Date:  2005-07-14       Impact factor: 23.059

6.  Relation of insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection.

Authors:  Hassan R Mohamed; Mohamed Yaqoot Abdel-Azziz; Kkaled Refaat Zalata; Ahmed M M Abdel-Razik
Journal:  Int J Health Sci (Qassim)       Date:  2009-07

7.  Relationship between clinical and pathologic findings in patients with chronic liver diseases.

Authors:  Lun-Gen Lu; Min-De Zeng; Yi-Min Mao; Ji-Qiang Li; De-Kai Qiu; Jing-Yuan Fang; Ai-Ping Cao; Mo-Bin Wan; Cheng-Zhong Li; Jun Ye; Xiong Cai; Cheng-Wei Chen; Ji-Yao Wang; Shan-Ming Wu; Jin-Shui Zhu; Xia-Qiu Zhou
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

8.  Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease.

Authors:  Julie Parkes; Indra Neil Guha; Scott Harris; William Mc Rosenberg; Paul J Roderick
Journal:  Comp Hepatol       Date:  2012-12-28

Review 9.  A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.

Authors:  Waqar Ahmad; Bushra Ijaz; Sana Gull; Sultan Asad; Saba Khaliq; Shah Jahan; Muhammad T Sarwar; Humera Kausar; Aleena Sumrin; Imran Shahid; Sajida Hassan
Journal:  Virol J       Date:  2011-02-08       Impact factor: 4.099

10.  Quantifying direct and indirect effect for longitudinal mediator and survival outcome using joint modeling approach.

Authors:  Cheng Zheng; Lei Liu
Journal:  Biometrics       Date:  2021-05-04       Impact factor: 1.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.